Related Experiment Video
Updated: Sep 20, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis
Kathryn E Luker1, Gary D Luker1,2,3
1Department of Radiology, Center for Molecular Imaging, University of Michigan Medical School, 109 Zina Pitcher Place, A524 BSRB, Ann Arbor, MI 48109-2200, USA.
Abstract:
In response to CXCL12, CXCR4 and ACKR3 both recruit β-arrestin 2, regulating the assembly of interacting proteins that drive signaling and contribute to the functions of both receptors in cancer and multiple other diseases. A prior proteomics study revealed that β-arrestin 2 scaffolds pyruvate kinase M2 (PKM2), an enzyme implicated in shifting cells to glycolytic metabolism and poor prognosis in cancer. We hypothesized that CXCL12 signaling regulates PKM2 protein interactions, oligomerization, and glucose metabolism. We used luciferase complementation in cell-based assays and a tumor xenograft model of breast cancer in NSG mice to quantify how CXCR4 and ACKR3 change protein interactions in the β-arrestin-ERK-PKM2 pathway. We also used mass spectrometry to analyze the effects of CXCL12 on glucose metabolism. CXCL12 signaling through CXCR4 and ACKR3 stimulated protein interactions among β-arrestin 2, PKM2, ERK2, and each receptor, leading to the dissociation of PKM2 from β-arrestin 2. The activation of both receptors reduced the oligomerization of PKM2, reflecting a shift from tetramers to dimers or monomers with low enzymatic activity. Mass spectrometry with isotopically labeled glucose showed that CXCL12 signaling increased intermediate metabolites in glycolysis and the pentose phosphate pathway, with ACKR3 mediating greater effects. These data establish how CXCL12 signaling regulates PKM2 and reprograms cellular metabolism.
Insights
CXCL12 signaling via CXCR4 and ACKR3 alters protein interactions, reducing pyruvate kinase M2 (PKM2) activity and reprogramming glucose metabolism in cancer. This impacts cell glycolysis and prognosis.
Area of Science:
- Molecular Biology
- Cancer Biology
- Metabolic Pathways
Background:
- CXCL12 (chemokine ligand) and its receptors CXCR4 and ACKR3 are crucial in cancer progression.
- β-arrestin 2 links these receptors to signaling pathways and interacts with pyruvate kinase M2 (PKM2), an enzyme involved in cancer metabolism.
- Dysregulated PKM2 activity and altered cellular metabolism are hallmarks of cancer, contributing to poor prognosis.
Purpose of the Study:
- To investigate how CXCL12 signaling through CXCR4 and ACKR3 influences protein interactions within the β-arrestin-ERK-PKM2 pathway.
- To determine the effect of CXCL12 signaling on PKM2 oligomerization and enzymatic activity.
- To analyze the impact of CXCL12 signaling on glucose metabolism, including glycolysis and the pentose phosphate pathway.
Main Methods:
- Cell-based assays using luciferase complementation to study protein interactions.
- Tumor xenograft model of breast cancer in NSG mice.
- Mass spectrometry to analyze protein interactions and glucose metabolism with isotopically labeled glucose.
Main Results:
- CXCL12 signaling stimulated protein interactions among β-arrestin 2, PKM2, ERK2, and receptors CXCR4/ACKR3.
- PKM2 dissociated from β-arrestin 2, and its oligomerization decreased, shifting towards less active dimers/monomers.
- CXCL12 signaling increased intermediate metabolites in glycolysis and the pentose phosphate pathway, with ACKR3 showing a more significant effect.
Conclusions:
- CXCL12 signaling reprograms cellular metabolism by regulating PKM2 interactions and oligomerization.
- The CXCR4/ACKR3-β-arrestin 2-PKM2 axis is a key regulator of metabolic shifts in cancer.
- Targeting this pathway could offer novel therapeutic strategies for cancer treatment.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway